DONNINI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.991
EU - Europa 5.777
AS - Asia 917
SA - Sud America 11
AF - Africa 9
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.718
Nazione #
US - Stati Uniti d'America 6.983
GB - Regno Unito 1.993
IE - Irlanda 1.125
SE - Svezia 613
CN - Cina 587
UA - Ucraina 574
IT - Italia 518
FR - Francia 343
DE - Germania 274
FI - Finlandia 160
VN - Vietnam 156
IN - India 111
BE - Belgio 89
TR - Turchia 42
ES - Italia 33
CZ - Repubblica Ceca 12
RU - Federazione Russa 10
AT - Austria 8
AU - Australia 8
BR - Brasile 8
CA - Canada 8
HK - Hong Kong 5
BG - Bulgaria 4
EU - Europa 4
RO - Romania 4
GR - Grecia 3
NG - Nigeria 3
NL - Olanda 3
SG - Singapore 3
TW - Taiwan 3
EE - Estonia 2
EG - Egitto 2
IL - Israele 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
CL - Cile 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 13.718
Città #
Southend 1.867
Dublin 1.112
Fairfield 1.072
Chandler 639
Ashburn 617
Houston 585
Woodbridge 496
Jacksonville 483
Wilmington 415
Seattle 408
Cambridge 353
Ann Arbor 261
Princeton 226
Siena 206
Dong Ket 154
Menlo Park 147
Nanjing 135
Beijing 132
Pune 99
Brussels 89
Boardman 82
San Diego 78
Helsinki 75
Fremont 66
San Mateo 66
Florence 45
Nanchang 36
Shenyang 34
Tianjin 33
Dearborn 31
Izmir 31
Kunming 31
Málaga 31
Hebei 30
London 25
New York 25
Rome 23
Shanghai 21
Lancaster 20
Prato 20
Changsha 17
Jinan 17
Norwalk 17
San Francisco 15
Jiaxing 14
Falls Church 13
Redwood City 13
Düsseldorf 12
Hangzhou 12
Phoenix 11
Ningbo 10
Zhengzhou 10
Milan 9
Taizhou 9
Kocaeli 7
Lanzhou 7
Tappahannock 7
Toronto 7
Vienna 7
Brno 6
Guangzhou 6
Hounslow 6
Prague 6
Bonndorf 5
Frankfurt am Main 5
Guarulhos 5
Melbourne 5
Philadelphia 5
Avezzano 4
Chicago 4
Edinburgh 4
Foiano della Chiana 4
Fuzhou 4
Hefei 4
Livorno 4
Renton 4
Saint Petersburg 4
Sofia 4
Washington 4
Acton 3
Amsterdam 3
Baotou 3
Canberra 3
Castelnuovo di Garfagnana 3
Changchun 3
Dallas 3
Falkenstein 3
Fucecchio 3
Gelsenkirchen 3
Genoa 3
Indiana 3
Lagos 3
Qingdao 3
Redmond 3
Rende 3
São Paulo 3
Atessa 2
Bangalore 2
Belgrade 2
Buffalo 2
Totale 10.665
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 322
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 276
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 219
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 208
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 208
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 199
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 187
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 185
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 182
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 174
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 173
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 172
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction 165
Development of phenol-enriched olive oil with phenolic compounds extracted from wastewater produced by physical refining 161
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 160
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 159
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 159
Studying vascular angiogenesis and senescence in zebrafish embryos 154
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 154
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 148
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 147
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 145
Differential contribution of bradykinin receptors in angiogenesis 144
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 144
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 144
Assessing vascular senescence in zebrafish. 142
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 142
Divergent effects of quercetin conjugates on angiogenesis. 138
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 138
Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends 137
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 136
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 135
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion 135
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line. 134
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 131
Targeting Integrins in Cancer 130
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 129
Oxidative Stress and Membrane Transport Systems 129
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 126
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 125
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 125
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. 122
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 122
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers. 121
Role of nitric oxide in the modulation of angiogenesis 120
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 119
Use of Nutraceuticals in Angiogenesis-Dependent Disorders 119
Expression and localization of placenta growth factor and PlGF receptors in human meningiomas 118
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 118
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk. 117
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 117
Biological characterization of nanocomposite hydrogels 114
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 113
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 113
Nitric oxide in tumor angiogenesis. 111
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 111
ETB receptors promote proliferation and migration of endothelial cells 109
Effect of Hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1 108
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. 108
Nitric oxide and angiogenesis 108
Constitutive and inducible nitric oxide synthase: role in angiogenesis 107
Hydrogen peroxide mediates endothelium-dependent dilation of coronary arterioles in obese rats on low carbohydrate diet. 106
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. 105
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways. 105
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 105
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 104
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation. 103
Role of nitric oxide in tumor angiogenesis 103
Nitric oxide modulates the angiogenic phenotype of middle T transformed endothelial cells. 102
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 101
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium 101
Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. 100
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 100
Endostatin: a promising drug for antiangiogenic therapy 99
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 99
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 99
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity. 99
Molecular mechanisms of VEGF-induced angiogenesis 98
Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium. 97
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 96
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 94
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 94
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 94
null 93
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 92
Development of new drugs in angiogenesis. 92
Role of prostaglandin E2 in EGFR mediated DU145 prostate cancer growth and epithelial mesenchymal transition 91
Activity of "NO-donor" or "NO-mediated" drugs 90
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 89
Nitric oxide and PGE-2 cross-talk in EGFR-driven epithelial tumor cells 89
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 88
Molecular mechanisms of resistance to anti-angiogenic drugs 88
Repurposing of drugs for triple negative breast cancer: an overview 87
Angiogenesis 87
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting. 86
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 85
Mitochondrial aldehyde dehydrogenase-2 activation prevents β amyloids induced endothelial cell dysfunction and restores angiogenesis. 84
Inflammation and tumor progression: role of prostaglandin E2 pathway 82
The heparin binding 25kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinases and TIMP-2 in endothelial cells 80
TAT-BH4 counteracts A beta toxicity on capillary endothelium 80
Totale 12.603
Categoria #
all - tutte 40.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.095 0 0 0 0 0 0 0 0 63 219 408 405
2019/20203.128 414 100 230 471 331 213 231 421 255 216 76 170
2020/20212.544 87 252 62 232 155 305 102 389 291 234 148 287
2021/20221.631 86 230 88 197 76 80 70 64 57 156 168 359
2022/20232.348 136 194 301 330 217 477 55 186 249 59 81 63
2023/20241.603 67 49 112 154 66 517 593 41 4 0 0 0
Totale 13.960